<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A number of chromosome aberrations occur nonrandomly as the sole aberration in malignant and premalignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>They imply very different prognoses </plain></SENT>
<SENT sid="2" pm="."><plain>For most of them the survival consequences have been established </plain></SENT>
<SENT sid="3" pm="."><plain>For <z:mp ids='MP_0004027'>trisomy</z:mp> 8, which is the most frequent numerical aberration in myeloid disorders, the prognostic implications have not been investigated </plain></SENT>
<SENT sid="4" pm="."><plain>In order to clarify survival in patients with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 as the sole aberration, the literature was searched for such cases </plain></SENT>
<SENT sid="5" pm="."><plain>In 115 patients survival data were available </plain></SENT>
<SENT sid="6" pm="."><plain>In 103 (89.6%), a myeloid disorder had been diagnosed </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0004808'>Acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) or a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) occurred in 100 cases (87.0%) </plain></SENT>
<SENT sid="8" pm="."><plain>The median survival was found to be 17.1 months </plain></SENT>
<SENT sid="9" pm="."><plain>On multivariate survival analysis (Cox), age above 60 and a leukemic diagnosis were found to be independent adverse prognostic indicators </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients survived significantly longer (median 21 months) than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients (median 15 months) </plain></SENT>
<SENT sid="11" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> age and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> the <z:mp ids='MP_0004027'>trisomy</z:mp> 8 clonal size was an independent prognostic factor </plain></SENT>
<SENT sid="12" pm="."><plain>An unexpected observation was a clear male preponderance in <z:mp ids='MP_0004027'>trisomy</z:mp> 8 MDS (about two-thirds of cases) </plain></SENT>
<SENT sid="13" pm="."><plain>In <z:mp ids='MP_0004027'>trisomy</z:mp> 8 AML an approximate 1:1 ratio was found </plain></SENT>
<SENT sid="14" pm="."><plain>Browsing of Mitelman's catalog confirmed these ratios </plain></SENT>
</text></document>